Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia.
Li DiHai ChenYan LuDuygu SelcenAndrew G EngelYuwei DaXin-Ming ShenPublished in: Neurology (2020)
This study provides Class IV evidence that channel blocker therapy in patients with SCCMS improves symptoms.